A single dose of 8-OH-DPAT reduces raphe binding of [3H]8-OH-DPAT and increases the effect of raphe stimulation on 5-HT metabolism.

8-Hydroxy-(di-n-propylamino)tetralin (8-OH-DPAT) has antidepressant-like effects in rats and selectively reduces presynaptic 5-HT1A function a day after administration. In the present study, the effect of 8-OH-DPAT (1 mg/kg s.c.) pretreatment on presynaptic (raphe nuclei) and postsynaptic (frontal cortex and hippocampus) [3H]8-OH-DPAT binding was studied. Bmax values were markedly reduced in the raphe, but not in the hippocampus and frontal cortex. Kd values were unchanged. Electrical stimulation of the dorsal raphe (300 microA, 1 ms, 20 Hz, 30 min) significantly increased 5-hydroxyindoleacetic acid in the frontal cortex, but not in the amygdala or the nucleus accumbens and caused smaller increases in the rest of the brain. The increase in the frontal cortex was significantly potentiated one day after giving 8-OH-DPAT. These results confirm the ability of 8-OH-DPAT to desensitise presynaptic 5-HT1A receptors and suggest that this may lead to a loss of feedback control so that, on neuronal stimulation, the increase of 5-HT function is enhanced. This effect may underlie the antidepressant-like action of 8-OH-DPAT pretreatment, i.e. its ability to oppose restraint-induced defects in locomotion on placement in an open field one day later. A requirement of presynaptic 5-HT for this behavioural effect is consistent with its prevention by the 5-HT synthesis inhibitor parachlorophenylalanine.

[1]  J. Henry,et al.  Rat brain slicer. A simple device for rapidly obtaining serial slabs of fresh brain , 1984, Brain Research Bulletin.

[2]  L. Cervo,et al.  Potential antidepressant properties of 8-hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin1A receptor agonist. , 1987, European journal of pharmacology.

[3]  C. Marsden,et al.  Effects of altered brain 5-hydroxytryptaminergic activity on brain tryptophan, 5-hydroxytryptamine and 5-hydroxyindoleacetic acid , 1976, Neuropharmacology.

[4]  M. Molliver,et al.  Organization of raphe-cortical projections in rat: A quantitative retrograde study , 1984, Brain Research Bulletin.

[5]  H. L. Goldberg,et al.  The comparative efficacy of buspirone and diazepam in the treatment of anxiety. , 1979, The American journal of psychiatry.

[6]  J. Pujol,et al.  Evidence for the localization of 5HT1A binding sites on serotonin containing neurons in the raphe dorsalis and raphe centralis nuclei of the rat brain , 1985, Neurochemistry International.

[7]  P. Soubrié,et al.  Reversal of helpless behavior in rats by putative 5-HT1A agonists , 1988, Biological Psychiatry.

[8]  J. Amsterdam,et al.  Open trial of gepirone in the treatment of major depressive disorder , 1987 .

[9]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[10]  J. Glowinski,et al.  Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT , 1983, Nature.

[11]  D. Eccleston,et al.  EFFECTS OF ELECTRICAL STIMULATION OF RAT MIDBRAIN ON 5‐HYDROXYTRYPTAMINE SYNTHESIS AS DETERMINED BY A SENSITIVE RADIOISOTOPE METHOD , 1972, Journal of neurochemistry.

[12]  G. Aghajanian,et al.  (-)-Propranolol blocks the inhibition of serotonergic dorsal raphe cell firing by 5-HT1A selective agonists. , 1986, European journal of pharmacology.

[13]  J. Palacios,et al.  The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site. , 1984, European journal of pharmacology.

[14]  S. Ross,et al.  Different effects on the responses of functional pre- and postsynaptic 5-HT1A receptors by repeated treatment of rats with the 5-HT1A receptor agonist 8-OH-DPAT , 1990, Neuropharmacology.

[15]  G. Kennett,et al.  Antidepressant-like action of 5-HT1A agonists and conventional antidepressants in an animal model of depression. , 1987, European journal of pharmacology.

[16]  M. Carli,et al.  Effect of 5-HT1A agonists on stress-induced deficit in open field locomotor activity of rats: Evidence that this model identifies anxiolytic-like activity , 1989, Neuropharmacology.

[17]  G. Kennett,et al.  8-OH-DPAT-induced hyperphagia: Its neural basis and possible therapeutic relevance , 1986, Appetite.

[18]  C. Dourish,et al.  Evidence that the hyperphagic response to 8-OH-DPAT is mediated by 5-HT1A receptors. , 1988, European journal of pharmacology.

[19]  J. Traber,et al.  5-HT1A receptor-related anxiolytics , 1987 .

[20]  C. Montigny,et al.  Serotoninergic but not noradrenergic neurons in rat central nervous system adapt to long-term treatment with monoamine oxidase inhibitors , 1985, Neuroscience.

[21]  D. Robinson,et al.  A 5-HT1A ligand with both antidepressant and anxiolytic properties. , 1988, Psychopharmacology bulletin.

[22]  C. de Montigny,et al.  Modification of 5‐HT neuron properties by sustained administration of the 5‐HT1A agonist gepirone: Electrophysiological studies in the rat brain , 1987, Synapse.

[23]  D. Middlemiss.  Blockade of the central 5-HT autoreceptor by β-adrenoceptor antagonists☆ , 1986 .

[24]  Effects of antidepressant treatments on 5-HT neurotransmission: electrophysiological and clinical studies. , 1984, Advances in biochemical psychopharmacology.

[25]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[26]  G. Aghajanian,et al.  Serotonin: Release in the Forebrain by Stimulation of Midbrain Raph� , 1967, Science.

[27]  P. Hutson,et al.  Hypothermia induced by the putative 5-HT1A agonists LY165163 and 8-OH-DPAT is not prevented by 5-HT depletion. , 1987, European journal of pharmacology.

[28]  S Garattini,et al.  Electrical stimulation of midbrain raphe: biochemical, behavioral and bioelectrical effects. , 1969, European journal of pharmacology.

[29]  C. Dourish,et al.  Neurochemical and behavioural evidence for mediation of the hyperphagic action of 8-OH-DPAT by 5-HT cell body autoreceptors. , 1986, European journal of pharmacology.

[30]  G. Kennett,et al.  Single administration of 5-HT1A agonists decreases 5-HT1A presynaptic, but not postsynaptic receptor-mediated responses: relationship to antidepressant-like action. , 1987, European journal of pharmacology.

[31]  J. Fozard,et al.  The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat. , 1984, European journal of pharmacology.

[32]  J. Amsterdam,et al.  Open trial of buspirone in the treatment of major depressive disorder. , 1986, Psychopharmacology bulletin.

[33]  S. Peroutka.  Selective interaction of novel anxiolytics with 5-hydroxytryptamine1A receptors , 1985, Biological Psychiatry.

[34]  D. Middlemiss,et al.  8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site. , 1983, European journal of pharmacology.

[35]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[36]  M. Hamon,et al.  Presynaptic 5-HT autoreceptors on serotonergic cell bodies and/or dendrites but not terminals are of the 5-HT1A subtype. , 1985, European journal of pharmacology.